Esketamine is approved in Europe for treating resistant major depressive disorder

December 20, 2019 / Depression, Ketamine, Neuroscience, Other substances, Papers, Psychology, Psychopharmacology, Publications / By /

Mahase, E. (2019). Esketamine is approved in Europe for treating resistant major depressive disorder.,  10.1136/bmj.l7069
Link to full text